All Type of News
7 Pharmaceutical Firms Identified with Extended Dividend Payout Records
Seven domestic pharmaceutical firms are ranked among 39 KSE (Korea Stock Exchange) listed companies that made a consecutive dividend payout for 24 years and more, according to a report released by the Korea Listed Com...
Mishandling of Medical Narcotics Discovered
The special inspection conducted by Suwon District Prosecutor's Office on the proper handling of medical narcotics revealed a total of 58 instances that were found in violation of the law.
The four-month inspection...
Janssen Korea Introduces New Once-Daily Reminyl PR
Janssen Korea announced early this week an availability of new, long-acting form of Reminyl PR (active ingredient: galantamine hydrobromide) for the treatment of mild to moderate Alzheimer's disease (AD) in the domest...
Daewoong's Urusa Records Over 36 Billion Won of Sales
Daewoong Pharmaceutical recently announced that its popular over-the-counter (OTC) medication Urusa (active ingredient: ursodeoxycholic acid) surpassed over 36 billion won of sales revenue last year, making it as the ...
Boryung Explains Reason for OTC Price Increases
In response to an industry report that Boryung Pharmaceutical is increasing prices for certain over-the-counter (OTC) products with established market recognitions, the company explained that the decision is not refle...
Government to Curb Prescription of High-Priced Medications
In an effort to curb the prescription of high-priced medications issued by hospitals and medical clinics, the Health Insurance Review Agency (HIRA) announced that individual healthcare providers could now obtain the l...
Successful Development of Allergy Diagnostic Kit with Domestic Specificity
The Korea Health Industry Development Institute (KHIDI) announced on March 8th of a successful development of an allergy diagnostic kit that is specific to certain allergens affecting the domestic population.
From ...
Domestic Firms Develop Silkworm Chrysalis Oil in Powder Form
Kolmar Korea and KunWha Pharmaceutical have successfully developed a novel functional ingredient from silkworm chrysalis, with potential commercialization opportunities as applied to cosmetic, nutraceutical and pharma...
Eisai Korea Obtains Sales and Marketing Rights for Excegran
Eisai Korea and Dong-A Pharmaceutical recently completed an agreement to transfer the domestic sales and marketing rights for anticonvulsant drug Excegran (active ingredient: zonisamide) from Dong-A to Eisai Korea, ef...
MSD Korea Receives Highest Quality Assessment Rating
MSD Korea recently received an award of recognition by Kyungin Regional Korea Food and Drug Administration (RKFDA) for the outstanding quality control and production management practices.
The recognition gave MSD K...
